Interestingly, we found that (1) an amplification or deletion pattern was only present in tumor cells but not in normal and premalignant Brca1-deficient mammary gland cells; (2) different tumors from different mice had different CNV profiles; (3) metastatic tumor shared very similar CNV profile with paired PT. Here, BRCA1 is linked to metastatic neoplasm.